Ting-yao Wu
Jinzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
AS1842856 Reduces β-Amyloid Burden via Inhibiting PLA2G4A-Mediated Lysosomal Dysfunction in APP/PS1 Mice.
Journal: CNS neuroscience & therapeutics
Published: November 20, 2025
Osmundacetone ameliorates Alzheimer's-like pathologies by inhibiting β-amyloid fibrillation, oxidative damage and neuroinflammation in APP/PS1 transgenic mice.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: June 04, 2024
Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP/PS1 transgenic mice.
Journal: Pharmacological research
Published: May 23, 2024
Potential Application Prospects of Biomolecule-Modified Two-Dimensional Chiral Nanomaterials in Biomedicine.
Journal: ACS biomaterials science & engineering
Published: March 20, 2024
From zinc homeostasis to disease progression: Unveiling the neurodegenerative puzzle.
Journal: Pharmacological research
Published: October 07, 2023
Astrocyte-derived lactoferrin reduces β-amyloid burden by promoting the interaction between p38 kinase and PP2A phosphatase in male APP/PS1 transgenic mice.
Journal: British journal of pharmacology
Published: November 25, 2022
Activation of vitamin D receptor inhibits Tau phosphorylation is associated with reduction of iron accumulation in APP/PS1 transgenic mice.
Journal: Neurochemistry international
Published: September 13, 2021
Vitamin D deficiency exacerbates Alzheimer-like pathologies by reducing antioxidant capacity.
Journal: Free radical biology & medicine
Published: May 11, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026